p53 tumor suppressor gene and ras oncogene mutations in hypopharyngeal squamous cell carcinomas

International Journal of Oncology

Volumn 11, Issue 1, 1997, Pages 133-137

  Miyahara, Hiroshi ^a   Yane, Katsunari ^a   Naitoh, Hiroaki ^a   Konishi, Noboru ^a   Kitahori, Yoshiteru ^a   Matsunaga, Takashi ^a   Hiasa, Yoshio ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypopharyngeal carcinoma; p53; Prognostic factor; ras; Squamous cell carcinoma

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; MALE; ONCOGENE H RAS; POINT MUTATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROAT SURGERY; TUMOR SUPPRESSOR GENE;

EID: 0030790358     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.1.133     Document Type: Article

References (11)

1. Bron L and Monnier P: Review; molecular alterations in head and neck squamous cell carcinoma. Clin Otolaryngol 20: 291-298, 1995.
2. Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037-1043, 1990.
3. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI and Harris CC: p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096, 1991.
4. Orita M, Iwahara H, Kanazawa H, Hayashi K and Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770, 1989.
5. Anwar K, Nakakuki K, Naiki H and Inuzuka M: ras gene mutations and HPV infections are common in human laryngeal carcinoma. Int J Cancer 53: 22-28, 1993.
6. Shidara K, Suzuki T, Hara F and Nakajima T: Lack of synergistic association between human papilloma virus and ras gene point mutation in laryngeal carcinomas. Laryngoscope 104: 1008-1012, 1994.
7. Otsu M, Hayashi Y, Amatu M and Itoh H: Immunohistochemical study of p53, EGF, EGF-receptor, v-erb B and ras p21 in squamous cell carcinoma of hypopharynx. Kobe J Med Sci 40: 139-153, 1994.
8. Montenarh M: Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene 7: 1673-1680, 1992.
9. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J: Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495-4499, 1992.
10. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM and Sidransky D: The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53: 4477-4480, 1993.
11. Frank JL, Bur ME, Garb JL, Kay S, Ware JL, Sismanis A and Neifeld JP: p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73: 181-186, 1994.